Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology
The indolent and aggressive behaviors of HCC might have a role in clinical trial (CT) results;
however, the indolent HCC is less analyzed compared to others cancer. Indolent profile …
however, the indolent HCC is less analyzed compared to others cancer. Indolent profile …
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues
Simple Summary Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
results in a relevant worsening of the prognosis of transplanted subjects. Pre-transplant …
results in a relevant worsening of the prognosis of transplanted subjects. Pre-transplant …
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment …
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide.
Curative treatments are available to a minority of patients, as HCC is often diagnosed at an …
Curative treatments are available to a minority of patients, as HCC is often diagnosed at an …
Hepatocellular Carcinoma and Liver Transplantation
U Tüysüz - 2024 - books.google.com
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide. It has the third
most common cancer-related death. Here, there are different treatment options for HCC that …
most common cancer-related death. Here, there are different treatment options for HCC that …
Angiopoietina-2 e il fattore di crescita endoteliale vascolare promuovono la migrazione e l'invasione degli sferoidi derivati dal carcinoma epatocellulare e dal …
A Romanzi - 2024 - iris.unimore.it
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) represent the most
common primary liver cancers. Although they arise from different backgrounds, they seem to …
common primary liver cancers. Although they arise from different backgrounds, they seem to …